Abacus Life, Inc. (NASDAQ:ABL – Get Free Report) insider Sean Mcnealy sold 75,800 shares of the business’s stock in a transaction on Friday, December 20th. The shares were sold at an average price of $8.00, for a total transaction of $606,400.00. Following the transaction, the insider now owns 12,361,500 shares of the company’s stock, valued at $98,892,000. This trade represents a 0.61 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Abacus Life Stock Down 3.3 %
Shares of ABL opened at $7.54 on Wednesday. Abacus Life, Inc. has a 1 year low of $7.07 and a 1 year high of $13.25. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.29 and a quick ratio of 1.29. The stock has a 50 day simple moving average of $8.37 and a two-hundred day simple moving average of $9.27. The firm has a market cap of $638.48 million, a P/E ratio of -41.89 and a beta of 0.13.
Abacus Life (NASDAQ:ABL – Get Free Report) last announced its quarterly earnings data on Thursday, November 7th. The company reported $0.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.14 by $0.06. The company had revenue of $28.15 million during the quarter, compared to analysts’ expectations of $26.08 million. Abacus Life had a negative net margin of 11.65% and a positive return on equity of 12.88%. During the same quarter in the prior year, the company earned $0.01 EPS. On average, analysts forecast that Abacus Life, Inc. will post 0.64 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Analysts Set New Price Targets
ABL has been the subject of several research analyst reports. Northland Capmk raised Abacus Life to a “strong-buy” rating in a research note on Thursday, October 24th. Northland Securities assumed coverage on Abacus Life in a report on Thursday, October 24th. They set an “outperform” rating and a $13.50 price objective for the company. B. Riley Financial reaffirmed a “buy” rating and issued a $16.00 target price on shares of Abacus Life in a research note on Friday, August 30th. Piper Sandler reissued an “overweight” rating and issued a $13.00 price target (up previously from $12.00) on shares of Abacus Life in a research note on Friday, November 8th. Finally, B. Riley raised their price objective on shares of Abacus Life from $16.00 to $17.00 and gave the company a “buy” rating in a research report on Monday, November 25th. Five investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $14.70.
Read Our Latest Research Report on Abacus Life
Abacus Life Company Profile
Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.
Featured Articles
- Five stocks we like better than Abacus Life
- Want to Profit on the Downtrend? Downtrends, Explained.
- 5 Reasons DraftKings Stock Looks Promising in the New Year
- Short Selling: How to Short a Stock
- Cybersecurity Stocks: 1 Immediate Buy and 1 Dip Opportunity
- Stock Dividend Cuts Happen Are You Ready?
- The Next 2 AI Winners Have Triple-Digit Upside Potential
Receive News & Ratings for Abacus Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abacus Life and related companies with MarketBeat.com's FREE daily email newsletter.